Key Points
- Axon CAO Jennifer Mak sold 1,134 shares on Dec. 19 at an average price of $600 for $680,400, trimming her stake by 7.62% to 13,740 shares valued at about $8.24M.
- Axon reported quarterly EPS of $1.17, missing the $1.63 consensus, while revenue of $710.6M beat estimates and increased 30.6% year‑over‑year.
- The stock has a market cap of $46.6B and a 52‑week range of $469.24–$885.91, with a consensus analyst rating of Moderate Buy and a $802.71 average price target (14 Buys, 4 Holds).
Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) CAO Jennifer Mak sold 1,134 shares of the company's stock in a transaction on Friday, December 19th. The stock was sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares of the company's stock, valued at $8,244,000. This represents a 7.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Axon Enterprise Price Performance
NASDAQ AXON opened at $591.02 on Wednesday. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The stock's 50-day moving average is $603.75 and its two-hundred day moving average is $704.42. The firm has a market cap of $46.64 billion, a P/E ratio of 187.03, a price-to-earnings-growth ratio of 137.85 and a beta of 1.40. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts' consensus estimates of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The company had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same period in the prior year, the company posted $1.45 EPS. The business's revenue was up 30.6% on a year-over-year basis. On average, analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Axon Enterprise
Institutional investors have recently added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $29,000. New Millennium Group LLC acquired a new position in shares of Axon Enterprise in the third quarter valued at $29,000. Banque Transatlantique SA acquired a new position in shares of Axon Enterprise in the first quarter valued at $31,000. Flaharty Asset Management LLC bought a new position in Axon Enterprise in the first quarter worth $33,000. Finally, Hemington Wealth Management boosted its stake in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company's stock worth $33,000 after buying an additional 17 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on AXON. Wall Street Zen cut shares of Axon Enterprise from a "hold" rating to a "sell" rating in a research note on Saturday, November 8th. Needham & Company LLC reiterated a "buy" rating and issued a $870.00 target price on shares of Axon Enterprise in a report on Wednesday, September 24th. Barclays cut their target price on shares of Axon Enterprise from $861.00 to $702.00 and set an "overweight" rating for the company in a research report on Thursday, November 6th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Axon Enterprise in a research report on Monday. Finally, Piper Sandler cut their price objective on Axon Enterprise from $893.00 to $753.00 and set an "overweight" rating for the company in a research report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus price target of $802.71.
View Our Latest Stock Report on Axon Enterprise
Axon Enterprise Company Profile
(
Get Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
